On the public citation graph
Designer vaccine nanodiscs for personalized cancer immunotherapy
0 signed · 1099 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/anie.201203193openalex-snapshot
Imageable Antigen‐Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
inferredcites →https://doi.org/10.1007/978-3-319-17350-4openalex-snapshot
Apolipoprotein Mimetics in the Management of Human Disease
inferredcites →https://doi.org/10.1007/978-3-319-17350-4_3openalex-snapshot
Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux
inferredcites →https://doi.org/10.1016/j.biomaterials.2014.10.053openalex-snapshot
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
inferredcites →https://doi.org/10.1016/j.jconrel.2015.04.010openalex-snapshot
Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens
inferredcites →https://doi.org/10.1016/j.vaccine.2010.09.077openalex-snapshot
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
inferredcites →https://doi.org/10.1016/s0022-1759(98)00204-xopenalex-snapshot
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
inferredcites →https://doi.org/10.1016/s1046-2023(02)00348-1openalex-snapshot
T-cell epitope mapping using the ELISPOT approach
inferredcites →https://doi.org/10.1021/acsbiomaterials.5b00375openalex-snapshot
Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals
inferredcites →https://doi.org/10.1021/acsnano.5b07522openalex-snapshot
High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
inferredcites →https://doi.org/10.1021/ja3063293openalex-snapshot
Colocalized Delivery of Adjuvant and Antigen Using Nanolipoprotein Particles Enhances the Immune Response to Recombinant Antigens
inferredcites →https://doi.org/10.1021/mp100171copenalex-snapshot
Efficient Delivery of Payload into Tumor Cells in a Controlled Manner by TAT and Thiolytic Cleavable PEG Co-Modified Liposomes
inferredcites →https://doi.org/10.1021/mp800051mopenalex-snapshot
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
inferredcites →https://doi.org/10.1021/nn302639ropenalex-snapshot
Releasable Layer-by-Layer Assembly of Stabilized Lipid Nanocapsules on Microneedles for Enhanced Transcutaneous Vaccine Delivery
inferredcites →https://doi.org/10.1021/nn500216yopenalex-snapshot
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
inferredcites →https://doi.org/10.1038/nature12978openalex-snapshot
Structure-based programming of lymph-node targeting in molecular vaccines
inferredcites →https://doi.org/10.1038/nature13988openalex-snapshot
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
inferredcites →https://doi.org/10.1038/nature14001openalex-snapshot
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
inferredcites →https://doi.org/10.1038/nature14426openalex-snapshot
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
inferredcites →https://doi.org/10.1038/nature18945openalex-snapshot
Neoantigen landscape dynamics during human melanoma–T cell interactions
inferredcites →https://doi.org/10.1038/nbt1332openalex-snapshot
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
inferredcites →https://doi.org/10.1038/nbt1339openalex-snapshot
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
inferredcites →https://doi.org/10.1038/ncomms4065openalex-snapshot
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation
inferredcites →https://doi.org/10.1038/nm.2198openalex-snapshot
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
inferredcites →https://doi.org/10.1038/nm.3105openalex-snapshot
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
inferredcites →https://doi.org/10.1038/nm.3161openalex-snapshot
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
inferredcites →https://doi.org/10.1038/nm.3773openalex-snapshot
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
inferredcites →https://doi.org/10.1038/nm.4200openalex-snapshot
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
inferredcites →https://doi.org/10.1038/nmat2960openalex-snapshot
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
inferredcites →https://doi.org/10.1038/nnano.2015.292openalex-snapshot
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
inferredcites →https://doi.org/10.1038/nrc2373openalex-snapshot
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
inferredcites →https://doi.org/10.1056/nejmoa1200690openalex-snapshot
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
inferredcites →https://doi.org/10.1073/pnas.1308672110openalex-snapshot
Dipeptides promote folding and peptide binding of MHC class I molecules
inferredcites →https://doi.org/10.1093/jnci/djs629openalex-snapshot
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
inferredcites →https://doi.org/10.1097/cji.0b013e318183af0bopenalex-snapshot
Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients
inferredcites →https://doi.org/10.1126/science.aaa4971openalex-snapshot
Neoantigens in cancer immunotherapy
inferredcites →https://doi.org/10.1126/scitranslmed.3006516openalex-snapshot
Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination
inferredcites →https://doi.org/10.1126/scitranslmed.aad7118openalex-snapshot
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
inferredcites →https://doi.org/10.1158/0008-5472.can-11-1400openalex-snapshot
Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
inferredcites →https://doi.org/10.1158/0008-5472.can-12-4241openalex-snapshot
Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity
inferredcites →https://doi.org/10.1158/2326-6066.cir-14-0019-topenalex-snapshot
Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1161/01.cir.0000087652.93751.0eopenalex-snapshot
Mitogen-Activated Protein Kinase Inhibition and Cardioplegia-Cardiopulmonary Bypass Reduce Coronary Myogenic Tone
inferredcites →https://doi.org/10.1172/jci200523373openalex-snapshot
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
inferredcites →https://doi.org/10.1182/blood-2014-04-567933openalex-snapshot
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
inferredcites →https://doi.org/10.1208/s12248-015-9780-2openalex-snapshot
A Review of Clinical Translation of Inorganic Nanoparticles
inferredcites →https://doi.org/10.3390/vaccines3030662openalex-snapshot
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
inferredcites →https://doi.org/10.3791/52771openalex-snapshot
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5013530openalex-extracted
Forced Intracellular Degradation of Xenoantigens as a Novel Modality for Cell-Based Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/9781394236145.ch18openalex-snapshot
Membrane Proteins: Challenging Biotherapeutic Targets
inferred← citeshttps://doi.org/10.1002/9783527831371.ch10openalex-snapshot
Bone Implants (Bone Regeneration and Bone Cancer Treatments)
inferred← citeshttps://doi.org/10.1002/adbi.201800219openalex-snapshot
Biomimetic Nanoparticle Vaccines for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adbi.201800287openalex-snapshot
Improving Cancer Vaccine Efficiency by Nanomedicine
inferred← citeshttps://doi.org/10.1002/adfm.201802540openalex-snapshot
Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy
inferred← citeshttps://doi.org/10.1002/adfm.201808361openalex-snapshot
Recyclable Cytokines on Short and Injectable Polylactic Acid Fibers for Enhancing T‐Cell Function
inferred← citeshttps://doi.org/10.1002/adfm.202009860openalex-snapshot
Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues
inferred← citeshttps://doi.org/10.1002/adfm.202010587openalex-snapshot
Injectable Adhesive Hydrogel as Photothermal‐Derived Antigen Reservoir for Enhanced Anti‐Tumor Immunity
inferred← citeshttps://doi.org/10.1002/adfm.202100386openalex-snapshot
Endogenous Stimuli‐Activatable Nanomedicine for Immune Theranostics for Cancer
inferred← citeshttps://doi.org/10.1002/adfm.202105059openalex-snapshot
Developing Acid‐Responsive Glyco‐Nanoplatform Based Vaccines for Enhanced Cytotoxic T‐lymphocyte Responses Against Cancer and SARS‐CoV‐2
inferred← citeshttps://doi.org/10.1002/adfm.202404956openalex-snapshot
A Dual Enhancing Strategy of Novel Nanovaccine Based on TIM3 Silencing Nanoadjuvants and Desialylated Cancer Cell Membrane Antigens for Personalized Vaccination Immunotherapy of Cancer
inferred← citeshttps://doi.org/10.1002/adfm.202416147openalex-snapshot
Peptide Antigen‐Surfaced TLR9‐Adjuvanting Nanovaccines as a Versatile Therapeutic Modality to Eradicate Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.1002/adhm.201701395openalex-snapshot
Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections
inferred← citeshttps://doi.org/10.1002/adhm.201800424openalex-snapshot
Delivery Strategies for Immune Checkpoint Blockade
inferred← citeshttps://doi.org/10.1002/adhm.201801099openalex-snapshot
Strategies of Combination Drug Delivery for Immune Checkpoint Blockades
inferred← citeshttps://doi.org/10.1002/adhm.201900039openalex-snapshot
Simultaneous T Cell Activation and Macrophage Polarization to Promote Potent Tumor Suppression by Iron Oxide‐Embedded Large‐Pore Mesoporous Organosilica Core–Shell Nanospheres
inferred← citeshttps://doi.org/10.1002/adhm.201901203openalex-snapshot
Self‐Albumin Camouflage of Carrier Protein Prevents Nontarget Antibody Production for Enhanced LDL‐C Immunotherapy
inferred← citeshttps://doi.org/10.1002/adhm.202002081openalex-snapshot
Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adhm.202002104openalex-snapshot
Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adhm.202101651openalex-snapshot
Well‐Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/adhm.202200905openalex-snapshot
Peptide‐Based Cancer Vaccine Delivery via the STINGΔTM‐cGAMP Complex
inferred← citeshttps://doi.org/10.1002/adhm.202203028openalex-snapshot
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell‐Mediated Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/adhm.202300549openalex-snapshot
Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long‐Term Immune Memory by Reprogramming Tumor‐Associated Macrophages
inferred← citeshttps://doi.org/10.1002/adhm.202301687openalex-snapshot
Lipid Nanoparticle Delivery Alters the Adjuvanticity of the TLR9 Agonist CpG by Innate Immune Activation in Lymphoid Tissue
inferred← citeshttps://doi.org/10.1002/adhm.202303690openalex-snapshot
Uplifting Antitumor Immunotherapy with Lymph‐Node‐Targeted and Ratio‐Controlled Codelivery of Tumor Cell Lysate and Adjuvant
inferred← citeshttps://doi.org/10.1002/adhm.202401270openalex-snapshot
Bioconjugated Antibody‐Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two‐Step Immunomodulation of Myeloid Cells
inferred← citeshttps://doi.org/10.1002/adhm.202401851openalex-snapshot
Endoplasmic Reticulum Stress Nano‐Orchestrators for Precisely Regulated Immunogenic Cell Death as Potent Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/adhm.202404316openalex-snapshot
Neoantigen‐Displaying Protein Nanoparticles as a Therapeutic Cancer Vaccine Against Melanoma
inferred← citeshttps://doi.org/10.1002/adma.201606036openalex-snapshot
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
inferred← citeshttps://doi.org/10.1002/adma.201707112openalex-snapshot
PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.201803322openalex-snapshot
Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.201803953openalex-snapshot
Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.201806381openalex-snapshot
Breaking the Depth Dependence by Nanotechnology‐Enhanced X‐Ray‐Excited Deep Cancer Theranostics
inferred← citeshttps://doi.org/10.1002/adma.201901255openalex-snapshot
Biomimetic Nanotechnology toward Personalized Vaccines
inferred← citeshttps://doi.org/10.1002/adma.201903847openalex-snapshot
Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/adma.201904156openalex-snapshot
Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
inferred← citeshttps://doi.org/10.1002/adma.202002940openalex-snapshot
Biosynthesis of Self‐Assembled Proteinaceous Nanoparticles for Vaccination
inferred← citeshttps://doi.org/10.1002/adma.202006007openalex-snapshot
Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202007576openalex-snapshot
Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202008094openalex-snapshot
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
inferred← citeshttps://doi.org/10.1002/adma.202100106openalex-snapshot
Engineering the Deformability of Albumin‐Stabilized Emulsions for Lymph‐Node Vaccine Delivery
inferred← citeshttps://doi.org/10.1002/adma.202102570openalex-snapshot
Near‐Infrared‐Light Remote‐Controlled Activation of Cancer Immunotherapy Using Photothermal Conjugated Polymer Nanoparticles
inferred← citeshttps://doi.org/10.1002/adma.202103790openalex-snapshot
Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/adma.202109254openalex-snapshot
A Minimalist Binary Vaccine Carrier for Personalized Postoperative Cancer Vaccine Therapy
inferred← citeshttps://doi.org/10.1002/adma.202201054openalex-snapshot
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
inferred← citeshttps://doi.org/10.1002/adma.202202168openalex-snapshot
Two‐Pronged Intracellular Co‐Delivery of Antigen and Adjuvant for Synergistic Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202210452openalex-snapshot
Biomaterial‐Based In Situ Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/adma.202308155openalex-snapshot
Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment
inferred← citeshttps://doi.org/10.1002/adma.202310982openalex-snapshot
Extracellular Matrix‐Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/adma.202404645openalex-snapshot
Fluorinated Organic Polymers for Cancer Drug Delivery
inferred← citeshttps://doi.org/10.1002/adma.202409914openalex-snapshot
Transformable Gel‐to‐Nanovaccine Enhances Cancer Immunotherapy via Metronomic‐Like Immunomodulation and Collagen‐Mediated Paracortex Delivery
inferred← citeshttps://doi.org/10.1002/adma.202417704openalex-snapshot
Topology‐Oriented Lymph Node Drainage of Dendritic Polymer‐TLR Agonist Conjugates to Enhance Vaccine Immunogenicity
inferred← citeshttps://doi.org/10.1002/adma.202506011openalex-snapshot
Synthetic High‐Density Lipoprotein Mimicking Nanodiscs with Pt(IV) Prodrug Enable Tumor Targeting and cGAS‐STING Pathway Activation for Chemo‐Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202510229openalex-snapshot
A Programmable Nanovaccine Platform Based on M13 Bacteriophage for Personalized Cancer Vaccine and Therapy
inferred← citeshttps://doi.org/10.1002/adma.202520019openalex-snapshot
Bioinspired Engineered Virus‐Mimetic Vesicles for Enhanced Cytosolic Delivery of STING Agonists Into Dendritic Cells
inferred← citeshttps://doi.org/10.1002/adma.73533openalex-snapshot
Dendritic Lipopeptide Nanovaccines Orchestrate Multi‐Pattern Recognition Receptors Activation and Potentiate Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/adtp.201800060openalex-snapshot
Peptide Delivery Systems for Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/adtp.201800128openalex-snapshot
Advancing Cancer Immunotherapies with Nanotechnology
inferred← citeshttps://doi.org/10.1002/adtp.201900010openalex-snapshot
Synthetic, Supramolecular, and Self‐Adjuvanting CD8 + T‐Cell Epitope Vaccine Increases the Therapeutic Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/adtp.201900115openalex-snapshot
Recent Advances in Particulate Adjuvants for Cancer Vaccination
inferred← citeshttps://doi.org/10.1002/adtp.202000094openalex-snapshot
Robust Anti‐Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adtp.202000100openalex-snapshot
Engineered Ovalbumin Nanoparticles for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adtp.202100005openalex-snapshot
Lytic Polyplex Vaccines Enhance Antigen‐Specific Cytotoxic T Cell Response through Induction of Local Cell Death
inferred← citeshttps://doi.org/10.1002/adtp.202100079openalex-snapshot
Lipid Nature and Alkyl Length Influence Lymph Node Accumulation of Lipid‐Polyethylene Glycol Amphiphiles
inferred← citeshttps://doi.org/10.1002/adtp.202100083openalex-snapshot
Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics
inferred← citeshttps://doi.org/10.1002/adtp.202100093openalex-snapshot
Photothermal Therapy Combined with Neoantigen Cancer Vaccination for Effective Immunotherapy against Large Established Tumors and Distant Metastasis
inferred← citeshttps://doi.org/10.1002/adtp.202200239openalex-snapshot
Advances in Tumor Antigen‐Based Anticancer Immunotherapy: Recent Progress, Prevailing Challenges, and Future Perspective
inferred← citeshttps://doi.org/10.1002/adtp.202500124openalex-snapshot
Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy
inferred← citeshttps://doi.org/10.1002/advs.201801847openalex-snapshot
Emerging Nano‐/Microapproaches for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.201900037openalex-snapshot
Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.201900069openalex-snapshot
Targeting and Specific Activation of Antigen‐Presenting Cells by Endogenous Antigen‐Loaded Nanoparticles Elicits Tumor‐Specific Immunity
inferred← citeshttps://doi.org/10.1002/advs.201903164openalex-snapshot
Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
inferred← citeshttps://doi.org/10.1002/advs.202001108openalex-snapshot
Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy Efficacy
inferred← citeshttps://doi.org/10.1002/advs.202001447openalex-snapshot
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
inferred← citeshttps://doi.org/10.1002/advs.202002365openalex-snapshot
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202002577openalex-snapshot
Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202003504openalex-snapshot
Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
inferred← citeshttps://doi.org/10.1002/advs.202200027openalex-snapshot
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202201496openalex-snapshot
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
inferred← citeshttps://doi.org/10.1002/advs.202204335openalex-snapshot
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
inferred← citeshttps://doi.org/10.1002/advs.202300116openalex-snapshot
A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202300418openalex-snapshot
A Nanovaccine Based on Adjuvant Peptide FK‐13 and l ‐Phenylalanine Poly(ester amide) Enhances CD8+ T Cell‐Mediated Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/advs.202301339openalex-snapshot
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202306190openalex-snapshot
Bioinspired Lipoproteins of Furoxans–Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance
inferred← citeshttps://doi.org/10.1002/advs.202306336openalex-snapshot
Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202306889openalex-snapshot
A Thermosensitive Bi‐Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti‐Tumor Efficacy of Frameshift Neoantigens
inferred← citeshttps://doi.org/10.1002/advs.202307754openalex-snapshot
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention
inferred← citeshttps://doi.org/10.1002/advs.202414779openalex-snapshot
Therapeutic Black Phosphorus Nanosheets Elicit Neutrophil Response for Enhanced Tumor Suppression
inferred← citeshttps://doi.org/10.1002/advs.202500021openalex-snapshot
Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
inferred← citeshttps://doi.org/10.1002/advs.202509890openalex-snapshot
Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy
inferred← citeshttps://doi.org/10.1002/advs.202512139openalex-snapshot
Designer Solid Self‐Emulsifying Nanovaccines Enable Dual Modulation of Dendritic Cells and T Cells for Potent Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/agt2.194openalex-snapshot
Therapeutic dendritic cell vaccines engineered with antigen‐biomineralized Bi2S3 nanoparticles for personalized tumor radioimmunotherapy
inferred← citeshttps://doi.org/10.1002/agt2.359openalex-snapshot
Biomembrane‐inspired design of medical micro/nanorobots: From cytomembrane stealth cloaks to cellularized Trojan horses
inferred← citeshttps://doi.org/10.1002/anbr.202200080openalex-snapshot
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/ange.202002780openalex-snapshot
Improving Cancer Immunotherapy Outcomes Using Biomaterials
inferred← citeshttps://doi.org/10.1002/ange.202006117openalex-snapshot
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse
inferred← citeshttps://doi.org/10.1002/ange.202008386openalex-snapshot
Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/ange.202301566openalex-snapshot
Synthesis of Erythrocyte Nanodiscs for Bacterial Toxin Neutralization
inferred← citeshttps://doi.org/10.1002/ange.202312603openalex-snapshot
Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma
inferred← citeshttps://doi.org/10.1002/ange.202423280openalex-snapshot
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/anie.202002780openalex-snapshot
Improving Cancer Immunotherapy Outcomes Using Biomaterials
inferred← citeshttps://doi.org/10.1002/anie.202006117openalex-snapshot
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse
inferred← citeshttps://doi.org/10.1002/anie.202008386openalex-snapshot
Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/anie.202301566openalex-snapshot
Synthesis of Erythrocyte Nanodiscs for Bacterial Toxin Neutralization
inferred← citeshttps://doi.org/10.1002/anie.202312603openalex-snapshot
Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma
inferred← citeshttps://doi.org/10.1002/anie.202423280openalex-snapshot
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/asia.201801677openalex-snapshot
Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery
inferred← citeshttps://doi.org/10.1002/bmm2.70062openalex-snapshot
Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/btpr.3070openalex-snapshot
Nanoparticles in cancer immunotherapies: An innovative strategy
inferred← citeshttps://doi.org/10.1002/cbf.3978openalex-snapshot
Nucleic acid‐based vaccine for ovarian cancer cells; bench to bedside
inferred← citeshttps://doi.org/10.1002/cbic.202200582openalex-snapshot
Self‐Assembling Peptide‐Based Functional Biomaterials
inferred← citeshttps://doi.org/10.1002/cbic.202200805openalex-snapshot
Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens
inferred← citeshttps://doi.org/10.1002/cnma.202100062openalex-snapshot
Nano‐ and Microscale Drug Delivery Approaches for Therapeutic Immunomodulation
inferred← citeshttps://doi.org/10.1002/cplu.202100548openalex-snapshot
Smart Drug Delivery Systems Based on DNA Nanotechnology
inferred← citeshttps://doi.org/10.1002/ddr.22244openalex-snapshot
Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/eji.201948225openalex-snapshot
Icaritin promotes tumor T‐cell infiltration and induces antitumor immunity in mice
inferred← citeshttps://doi.org/10.1002/fft2.441openalex-snapshot
Functions of immunologically active peptides and their roles in intestinal inflammation
inferred← citeshttps://doi.org/10.1002/jgm.3089openalex-snapshot
Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination
inferred← citeshttps://doi.org/10.1002/jlb.5bt0119-016ropenalex-snapshot
At the bench: Engineering the next generation of cancer vaccines
inferred← citeshttps://doi.org/10.1002/mabi.201800410openalex-snapshot
A Self‐Delivery Chimeric Peptide for Photodynamic Therapy Amplified Immunotherapy
inferred← citeshttps://doi.org/10.1002/mas.21616openalex-snapshot
IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT
inferred← citeshttps://doi.org/10.1002/smll.201701864openalex-snapshot
Surface‐Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/smll.201703110openalex-snapshot
Deep Tumor Penetrating Bioparticulates Inspired Burst Intracellular Drug Release for Precision Chemo‐Phototherapy
inferred← citeshttps://doi.org/10.1002/smll.201801372openalex-snapshot
Personalized Cancer Immunotherapy via Transporting Endogenous Tumor Antigens to Lymph Nodes Mediated by Nano Fe3O4
inferred← citeshttps://doi.org/10.1002/smll.202107732openalex-snapshot
GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/smll.202205819openalex-snapshot
Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines
inferred← citeshttps://doi.org/10.1002/smll.202302756openalex-snapshot
Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria
inferred← citeshttps://doi.org/10.1002/smll.202303438openalex-snapshot
Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/smll.202306892openalex-snapshot
Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity
inferred← citeshttps://doi.org/10.1002/smll.202307299openalex-snapshot
Advances in Immunomodulatory MOFs for Biomedical Applications
inferred← citeshttps://doi.org/10.1002/smll.202308327openalex-snapshot
Platelet Membrane‐Derived Nanodiscs for Neutralization of Endogenous Autoantibodies and Exogenous Virulence Factors
inferred← citeshttps://doi.org/10.1002/smll.202308539openalex-snapshot
Manipulating Redox Homeostasis of Cancer Stem Cells Overcome Chemotherapeutic Resistance through Photoactivatable Biomimetic Nanodiscs
inferred← citeshttps://doi.org/10.1002/smll.202407649openalex-snapshot
Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications
inferred← citeshttps://doi.org/10.1002/smll.202507547openalex-snapshot
Mesoporous Silica: A Promising Adjuvant for Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/smll.75014openalex-snapshot
Nanomaterials‐Based Immunotherapy for Atherosclerosis
inferred← citeshttps://doi.org/10.1002/smtd.202101516openalex-snapshot
Nanodisc‐Mediated Conversion of Virustatic Antiviral Antibody to Disrupt Virus Envelope in Infected Cells
inferred← citeshttps://doi.org/10.1002/smtd.202300019openalex-snapshot
A Multivalent Personalized Vaccine Orchestrating Two‐Signal Activation Rebuilds the Bridge Between Innate and Adaptive Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/sstr.202300016openalex-snapshot
Emerging Nano‐Immunotherapeutic Approaches to Glioma
inferred← citeshttps://doi.org/10.1002/sstr.202500370openalex-snapshot
Cell Shuttling in Multifunctional Microsized Needles
inferred← citeshttps://doi.org/10.1002/wnan.1559openalex-snapshot
Nanovaccines for cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/wnan.1574openalex-snapshot
Advances of functional nanomaterials for cancer immunotherapeutic applications
inferred← citeshttps://doi.org/10.1002/wnan.1590openalex-snapshot
Nanotechnology platforms for cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/wnan.1612openalex-snapshot
Regulation of cancer‐immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy
inferred← citeshttps://doi.org/10.1002/wnan.1646openalex-snapshot
Biogenic nanoparticles as immunomodulator for tumor treatment
inferred← citeshttps://doi.org/10.1002/wnan.1717openalex-snapshot
The synergistic strategies for the immuno‐oncotherapy with photothermal nanoagents
inferred← citeshttps://doi.org/10.1002/wnan.70044openalex-snapshot
Advances in Peptide‐Based Cancer Vaccines: Materials, Targeting, and Delivery Strategies
inferred← citeshttps://doi.org/10.1007/164_2023_685openalex-snapshot
Nanomedicine – Immune System Interactions: Limitations and Opportunities for the Treatment of Cancer
inferred← citeshttps://doi.org/10.1007/978-1-0716-1884-4_35openalex-snapshot
Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines
inferred← citeshttps://doi.org/10.1007/978-1-0716-4542-0_1openalex-snapshot
Current Landscape of Therapeutic Cancer Vaccines
inferred← citeshttps://doi.org/10.1007/978-1-0716-4542-0_10openalex-snapshot
Nanoparticles-Assisted Peptide Cancer Vaccine Delivery
inferred← citeshttps://doi.org/10.1007/978-3-030-29022-1_8openalex-snapshot
Artificial Life and Therapeutic Vaccines Against Cancers that Originate in Viruses
inferred← citeshttps://doi.org/10.1007/978-3-030-58174-9_13openalex-snapshot
Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-76263-6_6openalex-snapshot
Cancer Nanoimmunotherapy: Recent Advances and New Opportunities
inferred← citeshttps://doi.org/10.1007/978-3-030-78338-9_2openalex-snapshot
Cancer Immunotherapy Strategies: Basic Principles
inferred← citeshttps://doi.org/10.1007/978-3-030-78338-9_6openalex-snapshot
Nanoparticle Systems Applied for Immunotherapy in Various Treatment Modalities
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_111-1openalex-snapshot
High-Density Lipoproteins and Cancer, with an Emphasis on Their Role in Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-031-01669-1_6openalex-snapshot
Immunomodulatory Protein Nanoparticles in Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-3-032-00761-2_111openalex-snapshot
High-Density Lipoproteins and Cancer, with an Emphasis on Their Role in Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-319-98065-2_4openalex-snapshot
Cancer Stem Cells (CSCs) and Their Application in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-981-15-7998-1_4openalex-snapshot
Prospects of Cell Immobilization in Cancer Research and Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-981-16-1247-3_120-1openalex-snapshot
Nanotechnology in Cancer Diagnosis and Therapy
inferred← citeshttps://doi.org/10.1007/978-981-16-5422-0_120openalex-snapshot
Nanotechnology in Cancer Diagnosis and Therapy
inferred← citeshttps://doi.org/10.1007/978-981-16-6379-6_5openalex-snapshot
Nanotechnology and Immunomodulators in Cancer
inferred← citeshttps://doi.org/10.1007/978-981-16-6379-6_6openalex-snapshot
Advancements in the Field of Oral, Intravenous, and Inhaled Immunomodulators Using Nanotechnology
inferred← citeshttps://doi.org/10.1007/978-981-19-9786-0_4openalex-snapshot
Biomaterial-Based Delivery Systems for Chemotherapeutics
inferred← citeshttps://doi.org/10.1007/978-981-97-3925-7_6openalex-snapshot
Targeting of Tumor Microenvironment Through Nano-Biomaterial-Based Chemotherapy
inferred← citeshttps://doi.org/10.1007/s00018-021-03842-6openalex-snapshot
Nanoparticle-based approaches to target the lymphatic system for antitumor treatment
inferred← citeshttps://doi.org/10.1007/s00210-025-03835-3openalex-snapshot
Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment
inferred← citeshttps://doi.org/10.1007/s00262-019-02448-zopenalex-snapshot
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
inferred← citeshttps://doi.org/10.1007/s00262-020-02729-yopenalex-snapshot
Combination therapies utilizing neoepitope-targeted vaccines
inferred← citeshttps://doi.org/10.1007/s00262-024-03693-7openalex-snapshot
Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma
inferred← citeshttps://doi.org/10.1007/s00432-022-04190-zopenalex-snapshot
Recent advances in sonodynamic immunotherapy
inferred← citeshttps://doi.org/10.1007/s10544-019-0397-6openalex-snapshot
Investigation of parameters that determine Nano-DC vaccine transport
inferred← citeshttps://doi.org/10.1007/s10904-026-04275-zopenalex-snapshot
Facile Synthesis and Characterization of Copper Hybrid Nanoflowers Using β-hydroxyamide–based Compounds: Investigation of their Anticancer Activity and Molecular Docking Analysis
inferred← citeshttps://doi.org/10.1007/s11033-021-06876-yopenalex-snapshot
Nanotechnology-based products for cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s11051-020-05129-6openalex-snapshot
Nanodiagnosis and nanotreatment of colorectal cancer: an overview
inferred← citeshttps://doi.org/10.1007/s11051-023-05792-5openalex-snapshot
Research progress on tumor whole-cell vaccines prepared with nanoparticles for tumor immunotherapy
inferred← citeshttps://doi.org/10.1007/s11051-025-06293-3openalex-snapshot
Scaling nanopharmaceutical production for personalized medicine: challenges and strategies
inferred← citeshttps://doi.org/10.1007/s11426-018-9397-5openalex-snapshot
Precise nanomedicine for intelligent therapy of cancer
inferred← citeshttps://doi.org/10.1007/s11427-023-2465-xopenalex-snapshot
Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines
inferred← citeshttps://doi.org/10.1007/s11431-021-2011-7openalex-snapshot
Fabrication of subunit nanovaccines by physical interaction
inferred← citeshttps://doi.org/10.1007/s11523-020-00788-wopenalex-snapshot
Vaccine Therapies for Cancer: Then and Now
inferred← citeshttps://doi.org/10.1007/s11705-020-2034-6openalex-snapshot
Radial porous SiO2 nanoflowers potentiate the effect of antigen/adjuvant in antitumor immunotherapy
inferred← citeshttps://doi.org/10.1007/s11814-021-0985-zopenalex-snapshot
Emerging strategies for biomaterial-assisted cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s11912-018-0738-2openalex-snapshot
Transformation of Old Concepts for a New Era of Cancer Immunotherapy: Cytokine Therapy and Cancer Vaccines as Combination Partners of PD1/PD-L1 Inhibitors
inferred← citeshttps://doi.org/10.1007/s12274-018-2181-yopenalex-snapshot
Polyplex interaction strength as a driver of potency during cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12274-020-2904-8openalex-snapshot
Nanotechnologies for enhancing cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12274-024-6598-1openalex-snapshot
Nanoparticle delivery for central nervous system diseases and its clinical application
inferred← citeshttps://doi.org/10.1007/s13233-021-9095-3openalex-snapshot
Biomaterials as Antigen Delivery Carrier for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/s13337-026-00964-yopenalex-snapshot
Oncolytic viruses in cancer therapy development: the evolution of cell culture models in preclinical research
inferred← citeshttps://doi.org/10.1007/s13346-021-01015-3openalex-snapshot
Quantitation of lymphatic transport mechanism and barrier influences on lymph node-resident leukocyte access to lymph-borne macromolecules and drug delivery systems
inferred← citeshttps://doi.org/10.1007/s13346-022-01241-3openalex-snapshot
Nanocarriers for cancer nano-immunotherapy
inferred← citeshttps://doi.org/10.1007/s13770-022-00430-yopenalex-snapshot
Nanozyme-Based Enhanced Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/s40005-018-0399-zopenalex-snapshot
Nano delivery systems and cancer immunotherapy
showing the first 200 of 1051 · page through all 1051
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.